$MATN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Oncotelic Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Oncotelic Therapeutics, Inc.. Get notifications about new insider transactions in Oncotelic Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 24 2020 | MATN | MATEON THERAPEUTIC ... | Shah Amit B. | CHIEF FINANCIAL OFF ... | Buy | P | 0.19 | 8,220 | 1,562 | 60,000 | 51.8 K to 60 K (+15.87 %) |
Nov 24 2020 | MATN | MATEON THERAPEUTIC ... | Shah Amit B. | CHIEF FINANCIAL OFF ... | Buy | P | 0.19 | 20,088 | 3,817 | 51,780 | 31.7 K to 51.8 K (+63.39 %) |
Nov 24 2020 | MATN | MATEON THERAPEUTIC ... | Shah Amit B. | CHIEF FINANCIAL OFF ... | Buy | P | 0.20 | 31,692 | 6,180 | 31,692 | 0 to 31.7 K |
Mar 27 2020 | MATN | MATEON THERAPEUTIC ... | Trieu Vuong | CHIEF EXECUTIVE OFF ... | Buy | P | 0.12 | 3,000 | 360 | 15,761,808 | 15.8 M to 15.8 M (+0.02 %) |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | Schwieterman William D | President and CEO | Option Exercise | A | 0.22 | 500,000 | 110,000 | 500,000 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | Schwieterman William D | President and CEO | Option Exercise | A | 0.22 | 500,000 | 110,000 | 500,000 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | SANDAGE BOBBY W. JR., PHD. | Director | Option Exercise | A | 0.22 | 258,171 | 56,798 | 258,171 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | Reynolds Donald Rogers | Director | Option Exercise | A | 0.22 | 258,171 | 56,798 | 258,171 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | Pedder Simon | Director | Option Exercise | A | 0.22 | 258,171 | 56,798 | 258,171 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | A | 0.22 | 500,000 | 110,000 | 500,000 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | A | 0.22 | 250,000 | 55,000 | 250,000 | |
Jun 22 2018 | OXGN | MATEON THERAPEUTIC ... | CHAPLIN DAVID | Director | Option Exercise | A | 0.22 | 258,171 | 56,798 | 258,171 | |
Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | Reynolds Donald Rogers | Director | Option Exercise | P | 0.40 | 125,000 | 50,000 | 125,000 | |
Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | Reynolds Donald Rogers | Director | Option Exercise | P | 0.40 | 125,000 | 50,000 | 125,000 | |
Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | Reynolds Donald Rogers | Director | Buy | P | 0.00 | 250,000 | 0 | 280,000 | 30 K to 280 K (+833.33 %) |
Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | Schwieterman William D | President and CEO | Option Exercise | P | 0.40 | 312,500 | 125,000 | 312,500 | |
Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | Schwieterman William D | President and CEO | Option Exercise | P | 0.40 | 312,500 | 125,000 | 312,500 | |
Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | Schwieterman William D | President and CEO | Buy | P | 0.00 | 625,000 | 0 | 625,747 | 747 to 625.7 K (+83,668.01 %) |
Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | P | 0.40 | 125,000 | 50,000 | 125,000 | |
Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | P | 0.40 | 125,000 | 50,000 | 125,000 | |
Apr 16 2018 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Buy | P | 0.00 | 250,000 | 0 | 300,000 | 50 K to 300 K (+500.00 %) |
Jun 12 2017 | OXGN | MATEON THERAPEUTIC ... | Pedder Simon | Director | Option Exercise | A | 0.51 | 121,483 | 61,956 | 121,483 | |
Jun 12 2017 | OXGN | MATEON THERAPEUTIC ... | SANDAGE BOBBY W. JR., PHD. | Director | Option Exercise | A | 0.51 | 121,483 | 61,956 | 121,483 | |
Jun 12 2017 | OXGN | MATEON THERAPEUTIC ... | Reynolds Donald Rogers | Director | Option Exercise | A | 0.51 | 121,483 | 61,956 | 121,483 | |
Jan 13 2017 | OXGN | MATEON THERAPEUTIC ... | Schwieterman William D | President and CEO | Option Exercise | A | 0.38 | 550,000 | 206,250 | 550,000 | |
Jan 13 2017 | OXGN | MATEON THERAPEUTIC ... | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | A | 0.38 | 350,000 | 131,250 | 350,000 | |
Jan 13 2017 | OXGN | MATEON THERAPEUTIC ... | CHAPLIN DAVID | Chief Scientific Of ... | Option Exercise | A | 0.38 | 262,500 | 98,438 | 262,500 | |
Dec 20 2016 | OXGN | MATEON THERAPEUTIC ... | Reynolds Donald Rogers | Director | Buy | P | 0.36 | 9,950 | 3,532 | 30,000 | 20.1 K to 30 K (+49.63 %) |
Dec 20 2016 | OXGN | MATEON THERAPEUTIC ... | Reynolds Donald Rogers | Director | Buy | P | 0.35 | 7,350 | 2,573 | 20,050 | 12.7 K to 20.1 K (+57.87 %) |
Dec 20 2016 | OXGN | MATEON THERAPEUTIC ... | Reynolds Donald Rogers | Director | Buy | P | 0.34 | 12,700 | 4,318 | 12,700 | 0 to 12.7 K |
Oct 27 2016 | OXGN | MATEON THERAPEUTIC ... | SANDAGE BOBBY W PHD | Director | Option Exercise | A | 0.58 | 135,612 | 78,655 | 135,612 | |
Oct 27 2016 | OXGN | MATEON THERAPEUTIC ... | Reynolds Donald Rogers | Director | Option Exercise | A | 0.58 | 135,612 | 78,655 | 135,612 | |
Jun 03 2016 | OXGN | OXIGENE INC | Pedder Simon | Director | Option Exercise | A | 0.65 | 91,564 | 59,517 | 91,564 | |
Jun 03 2016 | OXGN | OXIGENE INC | McMahon Gerald PhD | Director | Option Exercise | A | 0.65 | 91,564 | 59,517 | 91,564 | |
Jun 03 2016 | OXGN | OXIGENE INC | DRISCOLL FREDERICK W | Director | Option Exercise | A | 0.65 | 91,564 | 59,517 | 91,564 | |
Mar 23 2016 | OXGN | OXIGENE INC | CHAPLIN DAVID | Chief Scientific Of ... | Option Exercise | A | 0.73 | 262,500 | 191,021 | 262,500 | |
Mar 23 2016 | OXGN | OXIGENE INC | Schwieterman William D | President and CEO | Option Exercise | A | 0.73 | 525,000 | 382,043 | 525,000 | |
Mar 23 2016 | OXGN | OXIGENE INC | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | A | 0.73 | 262,500 | 191,021 | 262,500 | |
Mar 23 2016 | OXGN | OXIGENE INC | Pedder Simon | Director | Option Exercise | A | 0.73 | 99,711 | 72,560 | 99,711 | |
Jul 20 2015 | OXGN | OXIGENE INC | LOAR MATTHEW M | Chief Financial Off ... | Option Exercise | A | 1.37 | 150,000 | 205,500 | 150,000 | |
May 29 2015 | OXGN | OXIGENE INC | RICHING BARBARA | Chief Financial Off ... | Option Exercise | A | 1.43 | 150,000 | 214,500 | 150,000 | |
May 29 2015 | OXGN | OXIGENE INC | Schwieterman William D | President and CEO | Option Exercise | A | 1.43 | 300,000 | 429,000 | 300,000 | |
May 29 2015 | OXGN | OXIGENE INC | Schwieterman William D | President and CEO | Option Exercise | A | 1.43 | 75,000 | 107,250 | 75,000 | |
May 29 2015 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Option Exercise | A | 1.43 | 77,996 | 111,534 | 77,996 | |
May 29 2015 | OXGN | OXIGENE INC | McMahon Gerald PhD | Director | Option Exercise | A | 1.43 | 77,996 | 111,534 | 77,996 | |
May 29 2015 | OXGN | OXIGENE INC | DRISCOLL FREDERICK W | Director | Option Exercise | A | 1.43 | 77,996 | 111,534 | 77,996 | |
May 29 2015 | OXGN | OXIGENE INC | CHAPLIN DAVID | Chief Scientific Of ... | Option Exercise | A | 1.43 | 225,000 | 321,750 | 225,000 | |
Jul 07 2014 | OXGN | OXIGENE INC | Schwieterman William D | Director | Option Exercise | A | 2.60 | 5,280 | 13,728 | 5,280 | |
Jul 07 2014 | OXGN | OXIGENE INC | McMahon Gerald PhD | Director | Grant | A | 0.00 | 3,847 | 0 | 18,611 | 14.8 K to 18.6 K (+26.06 %) |
Jul 07 2014 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Option Exercise | A | 2.60 | 5,280 | 13,728 | 5,280 | |
Jul 07 2014 | OXGN | OXIGENE INC | DRISCOLL FREDERICK W | Director | Option Exercise | A | 2.60 | 7,920 | 20,592 | 7,920 | |
May 30 2014 | OXGN | OXIGENE INC | RICHING BARBARA | Chief Financial Off ... | Option Exercise | A | 2.66 | 75,000 | 199,500 | 75,000 | |
May 19 2014 | OXGN | OXIGENE INC | CHAPLIN DAVID | President and CEO | Option Exercise | A | 2.95 | 150,000 | 442,500 | 150,000 | |
Jan 06 2014 | OXGN | OXIGENE INC | McMahon Gerald PhD | Director | Grant | A | 0.00 | 3,584 | 0 | 14,764 | 11.2 K to 14.8 K (+32.06 %) |
Jan 06 2014 | OXGN | OXIGENE INC | Schwieterman William D | Director | Option Exercise | A | 2.79 | 4,880 | 13,615 | 4,880 | |
Jan 06 2014 | OXGN | OXIGENE INC | CHAPLIN DAVID | Director | Option Exercise | A | 2.79 | 4,880 | 13,615 | 4,880 | |
Jan 06 2014 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Option Exercise | A | 2.79 | 4,880 | 13,615 | 4,880 | |
Jan 06 2014 | OXGN | OXIGENE INC | DRISCOLL FREDERICK W | Director | Option Exercise | A | 2.79 | 30,000 | 83,700 | 30,000 | |
Jan 06 2014 | OXGN | OXIGENE INC | DRISCOLL FREDERICK W | Director | Option Exercise | A | 2.79 | 7,310 | 20,395 | 7,310 | |
Aug 09 2013 | OXGN | OXIGENE INC | LANGECKER PETER | Chief Executive Off ... | Grant | A | 0.00 | 72,993 | 0 | 77,993 | 5 K to 78 K (+1,459.86 %) |
Jul 02 2013 | OXGN | OXIGENE INC | CHAPLIN DAVID | Director | Option Exercise | A | 2.70 | 10,060 | 27,162 | 10,060 | |
Jul 02 2013 | OXGN | OXIGENE INC | Wood Alastair JJ | Director | Option Exercise | A | 2.70 | 890 | 2,403 | 890 | |
Jul 02 2013 | OXGN | OXIGENE INC | Schwieterman William D | Director | Option Exercise | A | 2.70 | 10,060 | 27,162 | 10,060 | |
Jul 02 2013 | OXGN | OXIGENE INC | McMahon Gerald PhD | Director | Grant | A | 0.00 | 7,407 | 0 | 11,180 | 3.8 K to 11.2 K (+196.32 %) |
Jul 02 2013 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Option Exercise | A | 2.70 | 5,030 | 13,581 | 5,030 | |
Jul 02 2013 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Grant | A | 0.00 | 3,703 | 0 | 8,761 | 5.1 K to 8.8 K (+73.21 %) |
Jul 01 2013 | OXGN | OXIGENE INC | LANGECKER PETER | Chief Executive Off ... | Buy | P | 2.75 | 3,000 | 8,250 | 5,000 | 2 K to 5 K (+150.00 %) |
Jun 26 2013 | OXGN | OXIGENE INC | LANGECKER PETER | Chief Executive Off ... | Buy | P | 2.79 | 2,000 | 5,572 | 2,000 | 0 to 2 K |
Feb 28 2013 | OXGN | OXIGENE INC | RICHING BARBARA | CFO | Option Exercise | A | 4.18 | 15,000 | 62,700 | 15,000 | |
Feb 28 2013 | OXGN | OXIGENE INC | LANGECKER PETER | Chief Executive Off ... | Option Exercise | A | 4.18 | 8,333 | 34,832 | 8,333 | |
Jan 24 2013 | OXGN | OXIGENE INC | CHAPLIN DAVID | Director | Option Exercise | A | 4.36 | 6,260 | 27,294 | 6,260 | |
Jan 03 2013 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Option Exercise | A | 5.30 | 2,570 | 13,621 | 2,570 | |
Jan 03 2013 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Grant | A | 0.00 | 1,886 | 0 | 5,058 | 3.2 K to 5.1 K (+59.46 %) |
Jan 03 2013 | OXGN | OXIGENE INC | McMahon Gerald PhD | Director | Grant | A | 0.00 | 3,773 | 0 | 3,773 | 0 to 3.8 K |
Jan 03 2013 | OXGN | OXIGENE INC | Schwieterman William D | Director | Option Exercise | A | 5.30 | 5,140 | 27,242 | 5,140 | |
Jan 03 2013 | OXGN | OXIGENE INC | Wood Alastair JJ | Director | Option Exercise | A | 5.30 | 5,140 | 27,242 | 5,140 | |
Aug 01 2012 | OXGN | OXIGENE INC | LANGECKER PETER | Chief Executive Off ... | Option Exercise | A | 0.55 | 100,000 | 54,980 | 100,000 | |
Jul 03 2012 | OXGN | OXIGENE INC | Wood Alastair JJ | Director | Option Exercise | A | 0.55 | 50,500 | 27,826 | 50,500 | |
Jul 03 2012 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Option Exercise | A | 0.55 | 25,200 | 13,885 | 25,200 | |
Jul 03 2012 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Grant | A | 0.00 | 18,148 | 0 | 38,060 | 19.9 K to 38.1 K (+91.14 %) |
Jul 03 2012 | OXGN | OXIGENE INC | McMahon Gerald PhD | Director | Option Exercise | A | 0.55 | 50,500 | 27,826 | 50,500 | |
Jul 03 2012 | OXGN | OXIGENE INC | Schwieterman William D | Director | Option Exercise | A | 0.55 | 50,500 | 27,826 | 50,500 | |
Jan 04 2012 | OXGN | OXIGENE INC | Schwieterman William D | Director | Option Exercise | A | 0.99 | 28,300 | 28,017 | 28,300 | |
Jan 04 2012 | OXGN | OXIGENE INC | Wood Alastair JJ | Director | Option Exercise | A | 0.99 | 28,300 | 28,017 | 28,300 | |
Jan 04 2012 | OXGN | OXIGENE INC | McMahon Gerald PhD | Director | Option Exercise | A | 0.99 | 28,300 | 28,017 | 28,300 | |
Jan 04 2012 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Option Exercise | A | 0.99 | 14,200 | 14,058 | 14,200 | |
Jan 04 2012 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Grant | A | 0.00 | 10,101 | 0 | 19,912 | 9.8 K to 19.9 K (+102.96 %) |
Nov 02 2011 | OXGN | OXIGENE INC | Schwieterman William D | Director | Option Exercise | A | 1.65 | 17,300 | 28,545 | 17,300 | |
Dec 12 2011 | OXGN | OXIGENE INC | LANGECKER PETER | Chief Executive Off ... | Option Exercise | A | 1.03 | 200,000 | 206,000 | 200,000 | |
Nov 02 2011 | OXGN | OXIGENE INC | Wood Alastair JJ | Director | Grant | A | 0.00 | 12,121 | 0 | 17,871 | 5.8 K to 17.9 K (+210.80 %) |
Nov 02 2011 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Option Exercise | A | 1.65 | 8,600 | 14,190 | 8,600 | |
Nov 02 2011 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Grant | A | 0.00 | 6,061 | 0 | 9,811 | 3.8 K to 9.8 K (+161.63 %) |
Sep 22 2011 | OXGN | OXIGENE INC | McMahon Gerald PhD | Director | Option Exercise | A | 1.14 | 17,000 | 19,380 | 17,000 | |
Jan 04 2011 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 0.23 | 25,000 | 5,750 | 179,208 | 154.2 K to 179.2 K (+16.21 %) |
Jan 04 2011 | OXGN | OXIGENE INC | Wood Alastair JJ | Director | Grant | A | 0.23 | 25,000 | 5,750 | 115,000 | 90 K to 115 K (+27.78 %) |
Jan 04 2011 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 0.23 | 25,000 | 5,750 | 236,002 | 211 K to 236 K (+11.85 %) |
Jan 04 2011 | OXGN | OXIGENE INC | KESSEL MARK | Director | Grant | A | 0.23 | 25,000 | 5,750 | 115,000 | 90 K to 115 K (+27.78 %) |
Jan 04 2011 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Grant | A | 0.23 | 25,000 | 5,750 | 75,000 | 50 K to 75 K (+50.00 %) |
Jan 04 2011 | OXGN | OXIGENE INC | FICKLING ROY H | Director | Grant | A | 0.23 | 25,000 | 5,750 | 202,846 | 177.8 K to 202.8 K (+14.06 %) |
Sep 17 2010 | OXGN | OXIGENE INC | LANGECKER PETER | Chief Executive Off ... | Option Exercise | A | 0.28 | 200,000 | 56,000 | 200,000 | |
Sep 17 2010 | OXGN | OXIGENE INC | CHAPLIN DAVID | Chief Scientific Of ... | Option Exercise | A | 0.28 | 200,000 | 56,000 | 200,000 | |
Sep 17 2010 | OXGN | OXIGENE INC | MURPHY JAMES B | Chief Financial Off ... | Option Exercise | A | 0.28 | 200,000 | 56,000 | 200,000 | |
Jul 06 2010 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 0.38 | 25,000 | 9,503 | 154,208 | 129.2 K to 154.2 K (+19.35 %) |
Jul 06 2010 | OXGN | OXIGENE INC | Wood Alastair JJ | Director | Grant | A | 0.38 | 25,000 | 9,503 | 90,000 | 65 K to 90 K (+38.46 %) |
Jul 06 2010 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 0.38 | 25,000 | 9,503 | 292,002 | 267 K to 292 K (+9.36 %) |
Jul 06 2010 | OXGN | OXIGENE INC | KESSEL MARK | Director | Grant | A | 0.38 | 25,000 | 9,503 | 27,297,118 | 27.3 M to 27.3 M (+0.09 %) |
Jul 06 2010 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Buy | S | 0.39 | 25,000 | 9,750 | 50,000 | 25 K to 50 K (+100.00 %) |
Jul 06 2010 | OXGN | OXIGENE INC | FICKLING ROY H | Director | Grant | A | 0.38 | 25,000 | 9,503 | 177,846 | 152.8 K to 177.8 K (+16.36 %) |
Apr 29 2010 | OXGN | OXIGENE INC | MURPHY JAMES B | Chief Financial Off ... | Option Exercise | A | 1.06 | 400,000 | 424,000 | 400,000 | |
Apr 29 2010 | OXGN | OXIGENE INC | CHAPLIN DAVID | Chief Scientific Of ... | Option Exercise | A | 1.06 | 400,000 | 424,000 | 400,000 | |
Apr 29 2010 | OXGN | OXIGENE INC | LANGECKER PETER | Chief Executive Off ... | Option Exercise | A | 1.06 | 400,000 | 424,000 | 400,000 | |
Apr 06 2010 | OXGN | OXIGENE INC | HOWSON TAMAR D | Director | Grant | A | 1.17 | 25,000 | 29,250 | 25,000 | 0 to 25 K |
Jan 05 2010 | OXGN | OXIGENE INC | KESSEL MARK | Director | Grant | A | 1.14 | 35,000 | 39,900 | 65,000 | 30 K to 65 K (+116.67 %) |
Jan 05 2010 | OXGN | OXIGENE INC | Wood Alastair JJ | Director | Grant | A | 1.14 | 35,000 | 39,900 | 65,000 | 30 K to 65 K (+116.67 %) |
Jan 05 2010 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 1.14 | 35,000 | 39,900 | 186,002 | 151 K to 186 K (+23.18 %) |
Jan 05 2010 | OXGN | OXIGENE INC | LAFFER ARTHUR B | Director | Grant | A | 1.14 | 35,000 | 39,900 | 409,232 | 374.2 K to 409.2 K (+9.35 %) |
Jan 05 2010 | OXGN | OXIGENE INC | LAFFER ARTHUR B | Director | Grant | A | 1.14 | 8,662 | 9,875 | 374,232 | 365.6 K to 374.2 K (+2.37 %) |
Jan 05 2010 | OXGN | OXIGENE INC | FICKLING ROY H | Director | Grant | A | 1.14 | 35,000 | 39,900 | 152,846 | 117.8 K to 152.8 K (+29.70 %) |
Jan 05 2010 | OXGN | OXIGENE INC | FICKLING ROY H | Director | Grant | A | 1.14 | 7,017 | 7,999 | 117,846 | 110.8 K to 117.8 K (+6.33 %) |
Jan 05 2010 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 1.14 | 35,000 | 39,900 | 129,208 | 94.2 K to 129.2 K (+37.15 %) |
Jan 05 2010 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 1.14 | 7,017 | 7,999 | 94,208 | 87.2 K to 94.2 K (+8.05 %) |
Dec 10 2009 | OXGN | OXIGENE INC | KESSEL MARK | Director | Grant | A | 1.14 | 30,000 | 34,200 | 30,000 | 0 to 30 K |
Dec 10 2009 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 1.14 | 30,000 | 34,200 | 151,002 | 121 K to 151 K (+24.79 %) |
Dec 10 2009 | OXGN | OXIGENE INC | Wood Alastair JJ | Director | Grant | A | 1.14 | 30,000 | 34,200 | 30,000 | 0 to 30 K |
Dec 10 2009 | OXGN | OXIGENE INC | LAFFER ARTHUR B | Director | Grant | A | 1.14 | 30,000 | 34,200 | 365,570 | 335.6 K to 365.6 K (+8.94 %) |
Dec 10 2009 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 1.14 | 30,000 | 34,200 | 87,191 | 57.2 K to 87.2 K (+52.46 %) |
Oct 05 2009 | OXGN | OXIGENE INC | FICKLING ROY H | Director | Grant | A | 1.42 | 4,049 | 5,750 | 80,829 | 76.8 K to 80.8 K (+5.27 %) |
Dec 10 2009 | OXGN | OXIGENE INC | FICKLING ROY H | Director | Grant | A | 1.14 | 30,000 | 34,200 | 110,829 | 80.8 K to 110.8 K (+37.12 %) |
Oct 05 2009 | OXGN | OXIGENE INC | LAFFER ARTHUR B | Director | Grant | A | 1.42 | 5,369 | 7,624 | 335,570 | 330.2 K to 335.6 K (+1.63 %) |
Oct 05 2009 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 1.42 | 3,169 | 4,500 | 57,191 | 54 K to 57.2 K (+5.87 %) |
Sep 18 2009 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 2.18 | 1,432 | 3,122 | 121,002 | 119.6 K to 121 K (+1.20 %) |
Sep 18 2009 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 0.90 | 555 | 500 | 119,570 | 119 K to 119.6 K (+0.47 %) |
Sep 18 2009 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 0.93 | 806 | 750 | 119,015 | 118.2 K to 119 K (+0.68 %) |
Sep 18 2009 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 0.82 | 914 | 749 | 118,209 | 117.3 K to 118.2 K (+0.78 %) |
Sep 18 2009 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 0.78 | 961 | 750 | 117,295 | 116.3 K to 117.3 K (+0.83 %) |
Sep 18 2009 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 0.68 | 6,892 | 4,687 | 116,334 | 109.4 K to 116.3 K (+6.30 %) |
Sep 18 2009 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 0.69 | 1,086 | 749 | 109,442 | 108.4 K to 109.4 K (+1.00 %) |
Sep 18 2009 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 0.63 | 793 | 500 | 108,356 | 107.6 K to 108.4 K (+0.74 %) |
Sep 18 2009 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 0.78 | 641 | 500 | 107,563 | 106.9 K to 107.6 K (+0.60 %) |
Sep 18 2009 | OXGN | OXIGENE INC | SHIEBLER WILLIAM N | Director | Grant | A | 0.65 | 1,922 | 1,249 | 106,922 | 105 K to 106.9 K (+1.83 %) |
Sep 18 2009 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 2.18 | 1,720 | 3,750 | 54,022 | 52.3 K to 54 K (+3.29 %) |
Sep 18 2009 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 2.32 | 323 | 749 | 52,302 | 52 K to 52.3 K (+0.62 %) |
Sep 18 2009 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 2.23 | 336 | 749 | 51,979 | 51.6 K to 52 K (+0.65 %) |
Sep 18 2009 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 0.93 | 806 | 750 | 51,643 | 50.8 K to 51.6 K (+1.59 %) |
Sep 18 2009 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 0.82 | 914 | 749 | 50,837 | 49.9 K to 50.8 K (+1.83 %) |
Sep 18 2009 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 0.78 | 961 | 750 | 49,923 | 49 K to 49.9 K (+1.96 %) |
Sep 18 2009 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 0.68 | 5,514 | 3,750 | 48,962 | 43.4 K to 49 K (+12.69 %) |
Sep 18 2009 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 0.69 | 1,086 | 749 | 43,448 | 42.4 K to 43.4 K (+2.56 %) |
Sep 18 2009 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 0.62 | 1,209 | 750 | 42,362 | 41.2 K to 42.4 K (+2.94 %) |
Sep 18 2009 | OXGN | OXIGENE INC | Schwieterman William D | Director | Grant | A | 0.65 | 1,153 | 749 | 41,153 | 40 K to 41.2 K (+2.88 %) |